secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARINUS PHARMACEUTICALS, INC. (—)
CIK:        0001267813
Form:       8-K
Filed at:   2024-12-10T23:59:59+00:00
Accession:  0001558370-24-016118
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Marinus Pharma receives Nasdaq bid price and market value deficiency notices
----------------------------------------------------------------------------

- Nasdaq notified MRNS that bid price closed below $1.00 for 30 consecutive days.
- Company has until June 4, 2025 to regain compliance for a minimum 10 consecutive days.
- Also notified that market value of listed securities remained below $50 million for 30 days.
- Company may consider options to regain compliance but no assurance of success.
- Failure to comply may result in delisting; company could appeal or transfer to Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267813/000155837024016118/0001558370-24-016118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267813/000155837024016118/mrns-20241206x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-016118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer